Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel alone versus clopidogrel + aspirin after lower-extremity endovascular treatment in peripheral arterial disease
NL-OMON56168Recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Trial of clopidogrel and aspirin, sponsored by University Medical Center Utrecht. Started Aug 2022; status: recruiting.
02
Drugs
clopidogrelaspirin
Beyond the preview
Go deeper on NL-OMON56168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56168.